1.8512
price down icon1.27%   -0.0238
pre-market  Vorhandelsmarkt:  1.86   0.0088   +0.48%
loading

Finanzdaten der Qualigen Therapeutics Inc-Aktie (QLGN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
38.20%
1.6837
2.7247 1.333 1.2686 1.7408
Operating Income/Loss
38.20%
-1.6837
-2.7247 -1.333 -1.2686 -1.7408
Nonoperating Income/Loss
102.13%
-0.00167
0.0786 0.4828 -0.5277 0.263
Income/Loss From Continuing Operations Before Tax
36.31%
-1.6854
-2.6461 -0.8503 -1.7963 -1.4778
Income/Loss From Continuing Operations After Tax
36.31%
-1.6854
-2.6462 -0.8558 -1.7941 -1.4766
Net Income/Loss
36.31%
-1.6854
-2.6462 -0.8558 -1.7941 -1.5766
Preferred Stock Dividends And Other Adjustments
0.00159
- - 0.0276 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
15.59%
1.6839
1.4567 - - 7.6033
Diluted Average Shares
15.59%
1.6839
1.4567 0.1414 0.3879 7.6033
Basic Earnings Per Share
45.05%
-1.00
-1.82 - - -0.21
Diluted Earnings Per Share
45.05%
-1.00
-1.82 7.38 -4.70 -0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.00159
- - 0.0276 -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Kapitalisierung:     |  Volumen (24h):